ArticleTherapeutic advances in hematology2012

Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.

Vu H Duong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.